How long does ashwagandha take to work? What the trials actually did

'How long does ashwagandha take to work' is one of the most-asked questions about any plant on a British supplement shelf, and the honest answer is that nobody selling it to you is permitted to give you one. Not because the answer is being kept back. Because in British food law there is no authorised effect for ashwagandha, and a timescale is a statement about an effect. Print the weeks and you have printed the claim.

What does exist is a stack of clinical trials, each with a dose, a preparation, a fixed length and a measuring instrument. That is a different kind of information, and it is worth reading properly, because the figure repeated most often online was taken from those trials and then quietly reworded into something they never said.

Why is there no official answer to how long ashwagandha takes?

Start with the rule, because everything else follows from it. In Great Britain, any statement that a food or a food ingredient does something to your health is a health claim, and health claims are governed by retained Regulation (EC) 1924/2006. A claim may only be used if it appears on the Great Britain nutrition and health claims register, published by the Department of Health and Social Care, which lists the claims that were assessed and authorised and the claims that were assessed and rejected.

Plants never got that far. When the assessment programme stalled, the claims submitted for botanicals were parked - the trade calls them 'on hold' claims - and they have stayed parked ever since. Ashwagandha is one of them. It is Withania somnifera, a nightshade rather than a ginseng, whatever the trade name 'Indian ginseng' suggests, and its position in the register is the same as that of the other five plants in our tablet: no authorised health claim in Great Britain. That sits inside a wider set of rules governing what a British supplement label is allowed to say, and it is why every mention of traditional use on this site carries a dagger.

Now set a timescale beside that. 'Works in six weeks' is not a milder statement than 'works'. It contains 'works' and adds a deadline. If the effect itself cannot lawfully be stated, the speed at which it arrives cannot be stated either, and a brand printing one has not found a loophole. It has skipped a step.

Why a medicine can print a timescale and a supplement cannot

The comparison people reach for is a medicine, and the comparison is a useful one. A licensed medicine goes through an assessment of what it does, and the patient information leaflet that comes out of the process can tell you how quickly to expect something, because that sentence was regulated into existence. A food supplement has had no such assessment. No authorised effect means no authorised onset, and no timetable exists anywhere to be looked up. The absence is not a gap in the paperwork. It is the paperwork.

What dose and duration did the ashwagandha trials actually use?

None of that means the research does not exist. It means the research is not a licence to make claims, and that it should be read as what it is: a set of experiments, each with its own conditions written down in advance.

Take three of the most-cited. A 2012 randomised, double-blind, placebo-controlled trial in the Indian Journal of Psychological Medicine enrolled 64 adults with a history of chronic stress. Each took one capsule twice a day for 60 days; in the treatment group each capsule held 300 mg of a high-concentration full-spectrum extract of ashwagandha root, so 600 mg a day. The authors reported significantly lower scores on standard stress-assessment questionnaires, and lower serum cortisol, in the ashwagandha group than in the placebo group at Day 60.

A 2020 trial in Sleep Medicine took a different route: 150 adults scoring high on measures of non-restorative sleep, 120 mg a day of a standardised ashwagandha extract, six weeks. Alongside questionnaires the researchers used actigraphy - a wrist-worn motion monitor that estimates how long you took to fall asleep and how much of your time in bed was spent asleep. They reported self-reported sleep quality improving by 72 per cent in the treatment group against 29 per cent on placebo, with differences on the actigraphy measures at six weeks.

A 2021 systematic review and meta-analysis in PLOS One pooled five randomised controlled trials covering 400 participants. It reported a small but statistically significant effect on overall sleep - a standardised mean difference of -0.59, with a 95 per cent confidence interval running from -0.75 to -0.42 - and noted the effect looked more prominent among adults diagnosed with insomnia, at doses of 600 mg a day or more, and at treatment durations of eight weeks or more.

Two things run through all of it. Every dose is a concentrated extract measured in hundreds of milligrams: NIH's Office of Dietary Supplements, summarising a 2021 review of seven stress and anxiety trials in 491 adults, records a range of 240 to 1,250 mg a day of extract, or 12,000 mg a day of whole-root granules. And every outcome is a number off a questionnaire, a wrist monitor or a blood sample, rather than a sensation somebody noticed on a Tuesday.

The closest thing to an official number is a dose, not a date

The nearest thing to an official figure in this literature is not a duration at all. In 2022 a taskforce convened by the World Federation of Societies of Biological Psychiatry and the Canadian Network for Mood and Anxiety Treatments provisionally recommended ashwagandha root extract at 300 to 600 mg a day, standardised to 5 per cent withanolides, for generalised anxiety disorder, on the strength of three randomised trials totalling 165 people, and added that a larger, definitive study was still required. That is a guideline written for clinicians treating a diagnosed condition. It is not a shopping instruction, and a food supplement is not a treatment for anything.

Where did the '6 to 8 weeks' figure come from?

So where does the internet's number come from? From those calendars, and nowhere else. The trials ran for six weeks, eight weeks, sixty days, ninety days. Somebody read the durations, rounded them into 'six to eight weeks', and the phrase escaped into product pages, where it now reads as a forecast about you.

A trial length is a design decision taken before anybody swallows anything. Researchers pick it by balancing the size of effect they hope to detect against dropout, cost and how long they can keep several hundred people inside a protocol. It records what the researchers were prepared to run and fund. It records nothing whatsoever about when something began.

What the 2012 trial measured, and when it measured it

The 2012 trial is the cleanest illustration of the difference. Its final safety and efficacy assessments were carried out on Day 60. The contacts on Day 15, Day 30 and Day 45 were telephone calls to check compliance and note adverse reactions - not measurements. The design compares a starting point with an end point. It was never built to locate the moment in between at which a line was crossed, and it cannot be read as though it had been.

The meta-analysis's eight-week finding is the second misreading, and it is the more common one. That figure is a comparison between different studies of different lengths, not a measurement taken inside any single study. It says the pooled effect looked larger among the longer trials. Length of dosing is one candidate explanation. Who was recruited, which extract was used and how the outcome was scored are others, and a subgroup analysis cannot separate them.

The bodies that have actually assembled this literature are blunt about its limits. The US National Center for Complementary and Integrative Health notes that many of the studies have had small sample sizes and have used a variety of ashwagandha preparations, and that the evidence is unclear about effects on anxiety. The Office of Dietary Supplements concludes that because studies have used various preparations, with different extraction and standardisation processes, and various doses, it is difficult to identify specific extracts or recommended amounts. Neither publishes a number of weeks. Both are free to.

How much ashwagandha is in an AllMaleUp tablet?

Which brings this back to the pack, and to the paragraph a supplement brand would ordinarily leave out.

AllMaleUp is six botanicals totalling 100 mg per tablet: Ginseng 25 mg, Maca 25 mg, Tribulus 20 mg, Guarana 10 mg, Ashwagandha 10 mg, Catuaba 10 mg. A maximum of one tablet in any 24-hour period. The ashwagandha in our tablet is therefore 10 mg.

10 mg against 240 to 1,250 mg: the comparison in full

The trials above ran on 240 to 1,250 mg a day. The gap is not marginal and we are not going to dress it up. It is also wider than the two numbers make it look, because they are not the same kind of material. Our 10 mg is milled botanical. The trial doses were concentrated extracts, and an extract carries a drug-extract ratio: several kilograms of dried root reduced to one kilogram of extract before anything is weighed into a capsule. A milligram of extract therefore stands for several milligrams of plant. Setting 10 mg of one against 600 mg of the other understates the distance rather than exaggerating it.

We print the 10 mg anyway, beside the other five figures, because a blend that hides the split behind a single total is asking to be taken on trust. What we will not do is put a number of weeks next to it. There is no authorised effect for the plant; our tablet is nowhere near the amounts used in the research; and a timescale laid on top of both of those facts would be an invention, however confidently it was typeset.

What a British pack can honestly give you is on the back of the pack and on the blister foil: the six weights, the six Latin names, an origin for each plant, a best-before date and a batch code. Quote that code to us and we will send the certificate of analysis for the run of tablets in your hand. Those are things that can be checked. A number of weeks is not.

So: how long does ashwagandha take to work? The published trials ran for six to twelve weeks, at 240 to 1,250 mg a day of concentrated extract, and reported their results at the end of the protocol. That is the whole of what is on record, and it is a description of some experiments rather than an answer about you. Anybody converting it into a countdown has supplied the confidence themselves.

Common questions

† Describes the traditional use of these botanicals (UK 'on-hold' botanical claims under retained Regulation (EC) 1924/2006). Not authorised EFSA health claims. AllMaleUp is a food supplement, not a medicine.